Ivor Gillbe

ORCID: 0000-0003-4437-287X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neural Engineering
  • Neurological disorders and treatments
  • EEG and Brain-Computer Interfaces
  • Transcranial Magnetic Stimulation Studies
  • Functional Brain Connectivity Studies
  • Heart Rate Variability and Autonomic Control

Bioinduction (United Kingdom)
2014-2023

University of Antwerp
2020

Antwerp University Hospital
2020

There is growing interest in using adaptive neuromodulation to provide a more personalized therapy experience that might improve patient outcomes. Current implant technology, however, can be limited its algorithm capability. To enable exploration of algorithms with chronic implants, we designed and validated the 'Picostim DyNeuMo Mk-1' (DyNeuMo Mk-1 for short), fully-implantable, research stimulator titrates stimulation based on circadian rhythms (e.g. sleep, wake) patient's movement state...

10.1016/j.expneurol.2022.113977 article EN cc-by Experimental Neurology 2022-01-10

Deep brain stimulation (DBS) for Parkinson's disease, essential tremor and epilepsy is an established palliative treatment. DBS uses electrical neuromodulation to suppress symptoms. Most current systems provide a continuous pattern of fixed stimulation, with clinical follow-ups refine settings constrained normal office hours. An issue this management strategy that the impact on circadian, i.e. sleep-wake, rhythms not fully considered; either in device design or follow-up. Since devices can...

10.1109/smc42975.2020.9283187 article EN 2022 IEEE International Conference on Systems, Man, and Cybernetics (SMC) 2020-10-11

Abstract There is growing interest in using adaptive neuro-modulation to provide a more personalized therapy experience that might improve patient outcomes. Current implant technology, however, can be limited its algorithm capability. To enable exploration of algorithms with chronic implants, we designed and validated the ‘Picostim DyNeuMo Mk-1’ (DyNeuMo Mk-1 for short), fully-implantable, research stimulator titrates stimulation based on circadian rhythms (e.g. sleep, wake) patient’s...

10.1101/2020.09.10.292284 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-09-11

Providing clinicians with objective outcomes of neuromodulation therapy is a key unmet need, especially in emerging areas such as epilepsy and mood disorders. These diseases have episodic behavior circadian/multidien rhythm characteristics that are difficult to capture short clinical follow-ups. This work presents preliminary validation evidence for an implantable system integrated physiological event monitoring, initial focus on seizure tracking epilepsy. The was developed address currently...

10.1109/embc40787.2023.10340850 article EN 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2023-07-24
Coming Soon ...